Beta-blockers are a medication used to manage heart and blood pressure-related conditions. They are generally considered safe, but there are some side effects to be aware of. Beta-blockers are a ...

Even more specifically, there are two types of beta blockers: cardioselective and non-selective. The former targets receptors in the heart while the latter affects both heart sensors and others ...

Findings seen in patients following myocardial infarction. HealthDay News — Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial ...

MONDAY, Nov. 18, 2024 (HealthDay News) -- Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ...

Initiation of cardioselective beta-blockers was associated with rapid lung function decline in a long-term population study of individuals aged 45 years and older. Use of long-acting b-agonists (LABAs ...

1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy was not found to be noninferior to beta-blocker ...

β-blockers exert an antihypertensive effect via several mechanisms of action: central inhibition of sympathetic nervous system outflow, inhibition of the renin–angiotensin system by decreasing ...

Pharmacologic differences among β blockers suggest that perhaps one β blocker may be preferred to another in regard to efficacy, tolerability, and practicality. To evaluate the differences among ...

Beta-blockers are now a worldwide mainstay of heart failure treatment recommended in all international guidelines for chronic heart failure: this is a reversal of previous practice since they were ...

Beta-blocker interruption after a myocardial infarction (MI) failed to meet non-inferiority criteria in the ABYSS trial. Discontinuation resulted in higher hospitalization rates among patients with MI ...